share_log

Insider Purchase: Director at $AXDX (AXDX) Buys 200,000 Shares

Quiver Quantitative ·  Dec 4 10:01

JOHN PATIENCE, a director at $AXDX ($AXDX), bought 200,000 shares of the company on 12-03-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 44.1%. Following this trade, they now own 653,224 shares of $AXDX stock.

$AXDX Insider Trading Activity

$AXDX insiders have traded $AXDX stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here's a breakdown of recent trading of $AXDX stock by insiders over the last 6 months:

  • JOHN PATIENCE purchased 200,000 shares.
  • JACK W SCHULER sold 200,000 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AXDX Hedge Fund Activity

We have seen 12 institutional investors add shares of $AXDX stock to their portfolio, and 19 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • ARMISTICE CAPITAL, LLC added 493,000 shares (+30.7%) to their portfolio in Q3 2024
  • VANGUARD GROUP INC added 158,000 shares (+50.2%) to their portfolio in Q3 2024
  • GRIFFIN ASSET MANAGEMENT, INC. removed 135,299 shares (-9.8%) from their portfolio in Q3 2024
  • ALYESKA INVESTMENT GROUP, L.P. removed 80,547 shares (-100.0%) from their portfolio in Q2 2024
  • ORACLE INVESTMENT MANAGEMENT INC removed 42,101 shares (-100.0%) from their portfolio in Q2 2024
  • RENAISSANCE TECHNOLOGIES LLC added 41,078 shares (+inf%) to their portfolio in Q3 2024
  • WARBERG ASSET MANAGEMENT LLC removed 20,000 shares (-100.0%) from their portfolio in Q2 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment